Next Article in Journal
Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins
Previous Article in Journal
Utilisation of the Innovative [18F]-Labelled Radiotracer [18F]-BIBD-071 Within HR+ Breast Cancer Xenograft Mouse Models
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(1), 67; https://doi.org/10.3390/ph18010067
Action Date Notes Link
article xml file uploaded 9 January 2025 10:26 CET Original file -
article xml uploaded. 9 January 2025 10:26 CET Update https://www.mdpi.com/1424-8247/18/1/67/xml
article pdf uploaded. 9 January 2025 10:26 CET Version of Record https://www.mdpi.com/1424-8247/18/1/67/pdf
article supplementary file uploaded. 9 January 2025 10:26 CET - https://www.mdpi.com/1424-8247/18/1/67#supplementary
article html file updated 9 January 2025 10:28 CET Original file https://www.mdpi.com/1424-8247/18/1/67/html
Back to TopTop